Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 studyKarim Fizazi, Johann S. de Bono, John Staffurth et al.|The Lancet Oncology|2012Cited by 1.4k
Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle interventionDean Ornish, Peter R. Carroll, Mark Jesus M. Magbanua et al.|Proceedings of the National Academy of Sciences|2008Cited by 306
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trialShubham Pant, Eileen M. O’Reilly, Zev A. Wainberg et al.|Nature Medicine|2024Cited by 234